Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

NCT07008469 · clinicaltrials.gov ↗

PHASE3

Phase

ENROLLING_BY_INVITATION

Status

230

Enrollment

INDUSTRY

Sponsor class

Conditions

Myotonic Dystrophy Type 1
DM1
Myotonic Dystrophy
Myotonia
Myotonic Dystrophy 1
Myotonic Disorders
Steinert Myotonic Dystrophy
Steinert Disease

Interventions

DRUG: Del-desiran (AOC 1001)

Sponsor

Avidity Biosciences, Inc.